Supplier News Breaks Archives
In an agreement with the U.S. Department of Justice, Unilever plans to divest the venerable Alberto VO5 hair care brand so it can wrap up its acquisition of Alberto Culver Co.
Mylan Inc. has launched oxycodone and aspirin tablets, a treatment for moderate to severe pain.
Perrigo Co. is slated to change the dosing device for certain pediatric suspension pain relievers from a dropper to a new syringe dosing system designed to help consumers more accurately dispense the proper amount of medication.
Actresses Eva Mendes and Naomi Watts have been named celebrity ambassadors for Pantene, which plans a new advertising campaign featuring the two Hollywood stars
The Coca-Cola Co.'s Sprite Zero brand and Walgreens have stepped up with marketing support for the American Cancer Society's "Choose You" campaign to help women prevent cancer.
American Greetings Corp. has launched a special promotion with music star Taylor Swift and CoverGirl for Mother's Day.
Procter & Gamble Co. has announced a leadership change in and realignment of its beauty and grooming division and household care unit.
McNeil PPC's Visine eye care brand has introduced Visine Summer Spectrum Relief, billed as "the first and only eye drop targeted for summertime eye irritation and redness."
Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have been cleared by the Food and Drug Administration to market Tradjenta tablets, a treatment for type 2 diabetes.
Perrigo Co. has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter minoxidil foam, a generic version of Men's Rogaine Foam.
Pfizer Inc.'s Centrum multivitamins brand has partnered with celebrity personal trainer, Harley Pasternak to get Americans in "the best shape of their lives."
La Roche-Posay has launched its second "SOS - Save Our Skin" campaign, which aims to inform Americans about the dangers of ultraviolet rays and the importance of sun safety and get them to take action.
Watson Pharmaceuticals Inc. has released the Generess Fe birth control pill in the United States and begun shipping an authorized generic version of the attention deficit hyperactivity disorder (ADHD) drug Concerta.
Teva Pharmaceutical Industries Ltd. plans to acquire Cephalon Inc. in a $6.8 billion cash deal.